• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

Analyst Coverage
  • | Overview
  • | Corporate Governance
    • | Board Mandate
    • | Board Committee Charters
    • | Whistleblowing Policy
    • | Code of Conduct
  • | Investor Fact Sheet
  • | News Releases
    • | Fiscal 2012
    • | Archive
  • | Financial Statements
    • | Fiscal 2012
    • | Archive
  • | Annual Reports
  • | Regulatory Filings
  • | Analyst Coverage
  • | Presentations
    • | Corporate Presentations
    • | Scientific Presentations
  • | FAQ Investor Relations
  • | Stock Quote
  • | Shareholder Services
  • | Email Alerts
  • | Legal Disclaimer
  • | Contact IR

Analyst Coverage

 

Vista Partners   -  Ross Silver

 

 

 

Vista Partners receives compensation from the Company for their services.
Please note that any opinions, estimates, forecasts or conclusions regarding Helix BioPharma’s performance made by analysts are theirs alone and do not represent opinions, estimates, forecasts or conclusions of Helix BioPharma or its management. Helix BioPharma does not by its reference above imply any endorsement of or concurrence with such opinions, estimates, forecasts or conclusions.

 

 


 



  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.